Patent References 3514859 3551555 3553310 3555143 3639558 3867517 Method and reagent for determining immunologic materials Composition and method for determining the size and location of myocardial infarcts Method for detection of biological particles Indirect latex test for determination of immunoglobulins InventorAssigneeApplicationNo. 06/067680 filed on 08/20/1979US Classes:435/5, Involving virus or bacteriophage435/177, Enzyme or microbial cell is immobilized on or in an organic carrier435/188, Stablizing an enzyme by forming a mixture, an adduct or a composition, or formation of an adduct or enzyme conjugate435/7.92, Heterogeneous or solid phase assay system (e.g., ELISA, etc.)435/7.93, Competitive assay435/810, PACKAGED DEVICE OR KIT435/975, KIT436/509, Rheumatoid factors436/512, INVOLVING ANTIBODY FRAGMENTS436/513, INVOLVING IGA, IGD, IGE, OR IGM436/531, Carrier is synthetic resin436/800, FLUORESCENT DYES (E.G., RHODAMINE, ETC.)436/804, RADIOISOTOPE (E.G., RADIOIMMUNOASSAY, ETC.)436/808, Automated or kit436/811, TEST FOR NAMED DISEASE, BODY CONDITION OR ORGAN FUNCTION436/820HEPATITIS ASSOCIATED ANTIGENS AND ANTIBODIESExaminersPrimary: Wiseman, Thomas G.Attorney, Agent or FirmInternational ClassesG01N 33/563 (20060101)G01N 33/68 (20060101) G01N 33/543 (20060101) Foreign Application Priority Data1978-08-24 NLAbstractThe present invention relates to (1) a method for the detection and/or determination of an antigen specific immunoglobulin of a peculiar IgX class, in which X means M, A, D or E, comprising: (a) contacting and reacting the test-medium with either insolubilized anti-IgX against the antigen specific immunoglobulin of a peculiar IgX class to be determined, or antigen binding fragment of this anti-IgX, (2) incubating said contacted and reacted test medium with an antigen for which the immunoglobulin to be determined has specific affinity, and with a labelled antigen binding fragment of an antibody against said antigen, as well as (2) the novel coupling product comprising an antigen immunochemically bound to a labelled antigen binding fragment of an antibody against said antigen, and (3) test kit for the performance of said method (1). The labelling agent is detected and/or determined, which provides qualitative and/or quantitative information about the antigen specific immunoglobulin to be determined.Other References
|
| ||||||||||||||